Evidence map›Paper›PMID 41210735›Full record

ArticleACS omega2025

Consensus Virtual Screening and

Mariana H García-Hernández, Elena Jaime-Sánchez, Abraham Cardenas-Juarez, Carmen J Serrano, Lenci K Vázquez-Jiménez, Gildardo Rivera, Juan E López-Ramos, Edgar E Lara-Ramírez

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mariana H García-HernándezUnidad de Investigación Biomédica de Zacatecas, Instituto Mexicano del Seguro Social (IMSS), Zacatecas 98000, México.
Elena Jaime-SánchezLaboratorio de Biotecnología Farmacéutica, Centro de Biotecnología Genómica, Instituto Politécnico Nacional, Reynosa, Tamaulipas 88710, México.
Abraham Cardenas-JuarezUnidad de Investigación Biomédica de Zacatecas, Instituto Mexicano del Seguro Social (IMSS), Zacatecas 98000, México.
Carmen J SerranoUnidad de Investigación Biomédica de Zacatecas, Instituto Mexicano del Seguro Social (IMSS), Zacatecas 98000, México.
Lenci K Vázquez-JiménezLaboratorio de Biotecnología Farmacéutica, Centro de Biotecnología Genómica, Instituto Politécnico Nacional, Reynosa, Tamaulipas 88710, México.
Gildardo RiveraLaboratorio de Biotecnología Farmacéutica, Centro de Biotecnología Genómica, Instituto Politécnico Nacional, Reynosa, Tamaulipas 88710, México.ORCID https://orcid.org/0000-0001-9842-4167
Juan E López-RamosUnidad Profesional Interdisciplinaria de Ingeniería, Campus Zacatecas, Instituto Politécnico Nacional, Zacatecas 98160, México.
Edgar E Lara-RamírezLaboratorio de Biotecnología Farmacéutica, Centro de Biotecnología Genómica, Instituto Politécnico Nacional, Reynosa, Tamaulipas 88710, México.ORCID https://orcid.org/0000-0001-7112-3233

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling pathway is a key therapeutic target for inflammatory and neoplastic diseases such as rheumatoid arthritis (RA) and certain types of cancer. Although several inhibitors have been approved for medical use, their associated adverse effects limit their therapeutic use. Therefore, it is essential to search for new, safer inhibitors. In this work, we applied computer-aided approaches consisting of consensus molecular docking and molecular dynamics using the JAK2 structure as a filter of 3330 drugs approved by the Food and Drug Administration (FDA) retrieved from the ZINC20 database. The best predicted virtual hits were evaluated in an

Identifiers

PMID41210735
PMCPMC12593070

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.